Close

Softbank-Backed Zymergen (ZY) Crashes Over 70% as CEO Departs, Product Revenue Not Possible in 2021 and 'Immaterial' in 2022, At Least 6 Firms Downgrade

Go back to Softbank-Backed Zymergen (ZY) Crashes Over 70% as CEO Departs, Product Revenue Not Possible in 2021 and 'Immaterial' in 2022, At Least 6 Firms Downgrade
(NASDAQ: ZY) Delayed: 2.43 --0 (-0%)
Previous Close $2.43    52 Week High
Open $2.43    52 Week Low
Day High $2.43    P/E N/A 
Day Low $2.43    EPS
Volume 200